Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

The use of monoamine oxidase inhibitors in primary care.

Culpepper L.

J Clin Psychiatry. 2012;73 Suppl 1:37-41. doi: 10.4088/JCP.11096su1c.06. Review.

2.

Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.

Flockhart DA.

J Clin Psychiatry. 2012;73 Suppl 1:17-24. doi: 10.4088/JCP.11096su1c.03. Review.

3.

Issues in adherence to treatment with monoamine oxidase inhibitors and the rate of treatment failure.

Cohen LJ, Sclar DA.

J Clin Psychiatry. 2012;73 Suppl 1:31-6. doi: 10.4088/JCP.11096su1c.05. Review.

4.

The transdermal delivery system of monoamine oxidase inhibitors.

VanDenBerg CM.

J Clin Psychiatry. 2012;73 Suppl 1:25-30. doi: 10.4088/JCP.11096su1c.04. Review.

5.

The role of monoamine oxidase inhibitors in depression treatment guidelines.

Thase ME.

J Clin Psychiatry. 2012;73 Suppl 1:10-6. doi: 10.4088/JCP.11096su1c.02.

6.

MAOIs and depression treatment guidelines.

Thase ME.

J Clin Psychiatry. 2012 Jul;73(7):e24. doi: 10.4088/JCP.11096tx4c.

7.

MAOIs: issues in treatment adherence and rates of treatment failure.

Cohen LJ, Sclar DA.

J Clin Psychiatry. 2013 Jan;74(1):e02. doi: 10.4088/JCP.11096tx7c.

8.

Discussion: a fresh look at monoamine oxidase inhibitors for depression.

Cohen LJ, Sclar DA, Culpepper L, Flockhart DA, Hirschfeld RM, Thase ME, VanDenBerg CM.

J Clin Psychiatry. 2012;73 Suppl 1:42-5. doi: 10.4088/JCP.11096su1c.07. No abstract available.

9.

Revisiting monoamine oxidase inhibitors.

Krishnan KR.

J Clin Psychiatry. 2007;68 Suppl 8:35-41. Review.

10.

The use of MAOIs in primary care.

Culpepper L.

J Clin Psychiatry. 2012 May;73(5):e19. doi: 10.4088/JCP.11096tx8c.

11.

Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults.

Shulman KI, Fischer HD, Herrmann N, Huo CY, Anderson GM, Rochon PA.

J Clin Psychiatry. 2009 Dec;70(12):1681-6. doi: 10.4088/JCP.08m05041blu. Epub 2009 Oct 20.

PMID:
19852903
12.
13.
14.

MAOIs and transdermal delivery.

Vandenberg CM.

J Clin Psychiatry. 2012 Sep;73(9):e28. doi: 10.4088/JCP.11096tx6c.

15.

Translating the evidence on atypical depression into clinical practice.

Rapaport MH, Thase ME.

J Clin Psychiatry. 2007 Apr;68(4):e11. Review.

16.

Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants.

Stahl SM, Felker A.

CNS Spectr. 2008 Oct;13(10):855-70. Review.

PMID:
18955941
17.

Translating the evidence on atypical depression into clinical practice.

Hyman Rapaport M.

J Clin Psychiatry. 2007;68 Suppl 3:31-6. Review.

18.

Introduction: a fresh look at monoamine oxidase inhibitors for depression.

Cohen LJ, Sclar DA.

J Clin Psychiatry. 2012;73 Suppl 1:3-4. doi: 10.4088/JCP.11096su1c.00. No abstract available.

19.

Current place of monoamine oxidase inhibitors in the treatment of depression.

Shulman KI, Herrmann N, Walker SE.

CNS Drugs. 2013 Oct;27(10):789-97. doi: 10.1007/s40263-013-0097-3. Review.

PMID:
23934742
20.

CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression.

Fawcett J, Kravitz HM, Zajecka JM, Schaff MR.

J Clin Psychopharmacol. 1991 Apr;11(2):127-32.

PMID:
2056139

Supplemental Content

Support Center